nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—PTGS1—Alzheimer's disease	0.338	0.636	CbGaD
Sulindac—PTGS2—Alzheimer's disease	0.193	0.364	CbGaD
Sulindac—MAPK3—blood vessel—Alzheimer's disease	0.00562	0.0766	CbGeAlD
Sulindac—AKR1B1—embryo—Alzheimer's disease	0.00463	0.063	CbGeAlD
Sulindac—AKR1B1—forebrain—Alzheimer's disease	0.00409	0.0557	CbGeAlD
Sulindac—PTGDR2—cerebellum—Alzheimer's disease	0.00393	0.0536	CbGeAlD
Sulindac—AKR1B1—telencephalon—Alzheimer's disease	0.00376	0.0512	CbGeAlD
Sulindac—MAPK3—embryo—Alzheimer's disease	0.00335	0.0457	CbGeAlD
Sulindac—PPARD—forebrain—Alzheimer's disease	0.00322	0.0438	CbGeAlD
Sulindac—PTGDR2—brain—Alzheimer's disease	0.0032	0.0435	CbGeAlD
Sulindac—MAPK3—forebrain—Alzheimer's disease	0.00297	0.0404	CbGeAlD
Sulindac—PPARD—telencephalon—Alzheimer's disease	0.00296	0.0403	CbGeAlD
Sulindac—MAPK3—telencephalon—Alzheimer's disease	0.00273	0.0371	CbGeAlD
Sulindac—AKR1B1—nervous system—Alzheimer's disease	0.00222	0.0303	CbGeAlD
Sulindac—AKR1B1—central nervous system—Alzheimer's disease	0.00214	0.0291	CbGeAlD
Sulindac—AKR1B1—cerebellum—Alzheimer's disease	0.00209	0.0285	CbGeAlD
Sulindac—PPARD—nervous system—Alzheimer's disease	0.00175	0.0238	CbGeAlD
Sulindac—AKR1B1—brain—Alzheimer's disease	0.0017	0.0231	CbGeAlD
Sulindac—PPARD—central nervous system—Alzheimer's disease	0.00168	0.0229	CbGeAlD
Sulindac—PPARD—cerebellum—Alzheimer's disease	0.00164	0.0224	CbGeAlD
Sulindac—MAPK3—nervous system—Alzheimer's disease	0.00161	0.0219	CbGeAlD
Sulindac—MAPK3—central nervous system—Alzheimer's disease	0.00155	0.0211	CbGeAlD
Sulindac—PTGS1—blood vessel—Alzheimer's disease	0.00153	0.0208	CbGeAlD
Sulindac—MAPK3—cerebellum—Alzheimer's disease	0.00152	0.0206	CbGeAlD
Sulindac—PTGS2—blood vessel—Alzheimer's disease	0.00146	0.0199	CbGeAlD
Sulindac—PPARD—brain—Alzheimer's disease	0.00134	0.0182	CbGeAlD
Sulindac—MAPK3—brain—Alzheimer's disease	0.00123	0.0168	CbGeAlD
Sulindac—SLC22A6—brain—Alzheimer's disease	0.000942	0.0128	CbGeAlD
Sulindac—PTGS2—embryo—Alzheimer's disease	0.000871	0.0119	CbGeAlD
Sulindac—PTGS1—forebrain—Alzheimer's disease	0.000806	0.011	CbGeAlD
Sulindac—PTGS2—forebrain—Alzheimer's disease	0.000771	0.0105	CbGeAlD
Sulindac—PTGS1—telencephalon—Alzheimer's disease	0.000741	0.0101	CbGeAlD
Sulindac—PTGS2—telencephalon—Alzheimer's disease	0.000709	0.00965	CbGeAlD
Sulindac—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000681	0.00335	CcSEcCtD
Sulindac—Hyperglycaemia—Donepezil—Alzheimer's disease	0.000678	0.00334	CcSEcCtD
Sulindac—Pneumonia—Donepezil—Alzheimer's disease	0.000674	0.00332	CcSEcCtD
Sulindac—Bronchospasm—Memantine—Alzheimer's disease	0.000671	0.00331	CcSEcCtD
Sulindac—Pancreatitis—Memantine—Alzheimer's disease	0.000669	0.00329	CcSEcCtD
Sulindac—Depression—Donepezil—Alzheimer's disease	0.000668	0.00329	CcSEcCtD
Sulindac—Flatulence—Galantamine—Alzheimer's disease	0.000666	0.00328	CcSEcCtD
Sulindac—Sweating increased—Memantine—Alzheimer's disease	0.000665	0.00327	CcSEcCtD
Sulindac—Tension—Galantamine—Alzheimer's disease	0.000663	0.00327	CcSEcCtD
Sulindac—Dysgeusia—Galantamine—Alzheimer's disease	0.000662	0.00326	CcSEcCtD
Sulindac—Renal failure—Donepezil—Alzheimer's disease	0.000659	0.00324	CcSEcCtD
Sulindac—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000657	0.00323	CcSEcCtD
Sulindac—Nervousness—Galantamine—Alzheimer's disease	0.000656	0.00323	CcSEcCtD
Sulindac—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000655	0.00322	CcSEcCtD
Sulindac—Jaundice—Donepezil—Alzheimer's disease	0.000653	0.00322	CcSEcCtD
Sulindac—Conjunctivitis—Donepezil—Alzheimer's disease	0.000651	0.00321	CcSEcCtD
Sulindac—Sweating increased—Rivastigmine—Alzheimer's disease	0.00065	0.0032	CcSEcCtD
Sulindac—Pancytopenia—Memantine—Alzheimer's disease	0.000648	0.00319	CcSEcCtD
Sulindac—Sweating—Donepezil—Alzheimer's disease	0.000643	0.00316	CcSEcCtD
Sulindac—Haematuria—Donepezil—Alzheimer's disease	0.000639	0.00315	CcSEcCtD
Sulindac—Dysuria—Memantine—Alzheimer's disease	0.000638	0.00314	CcSEcCtD
Sulindac—Neutropenia—Memantine—Alzheimer's disease	0.000638	0.00314	CcSEcCtD
Sulindac—Vision blurred—Galantamine—Alzheimer's disease	0.000637	0.00314	CcSEcCtD
Sulindac—Epistaxis—Donepezil—Alzheimer's disease	0.000632	0.00311	CcSEcCtD
Sulindac—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000627	0.00309	CcSEcCtD
Sulindac—Anaemia—Galantamine—Alzheimer's disease	0.000625	0.00308	CcSEcCtD
Sulindac—Dysuria—Rivastigmine—Alzheimer's disease	0.000624	0.00307	CcSEcCtD
Sulindac—Hyperglycaemia—Memantine—Alzheimer's disease	0.000616	0.00303	CcSEcCtD
Sulindac—Pneumonia—Memantine—Alzheimer's disease	0.000612	0.00301	CcSEcCtD
Sulindac—Malaise—Galantamine—Alzheimer's disease	0.000609	0.003	CcSEcCtD
Sulindac—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000609	0.003	CcSEcCtD
Sulindac—Vertigo—Galantamine—Alzheimer's disease	0.000607	0.00299	CcSEcCtD
Sulindac—Depression—Memantine—Alzheimer's disease	0.000607	0.00299	CcSEcCtD
Sulindac—Syncope—Galantamine—Alzheimer's disease	0.000606	0.00298	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000603	0.00297	CcSEcCtD
Sulindac—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000602	0.00297	CcSEcCtD
Sulindac—Hepatitis—Donepezil—Alzheimer's disease	0.000602	0.00296	CcSEcCtD
Sulindac—Pneumonia—Rivastigmine—Alzheimer's disease	0.000599	0.00295	CcSEcCtD
Sulindac—Renal failure—Memantine—Alzheimer's disease	0.000598	0.00295	CcSEcCtD
Sulindac—Palpitations—Galantamine—Alzheimer's disease	0.000597	0.00294	CcSEcCtD
Sulindac—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000596	0.00294	CcSEcCtD
Sulindac—Loss of consciousness—Galantamine—Alzheimer's disease	0.000594	0.00292	CcSEcCtD
Sulindac—Depression—Rivastigmine—Alzheimer's disease	0.000594	0.00292	CcSEcCtD
Sulindac—Conjunctivitis—Memantine—Alzheimer's disease	0.000591	0.00291	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00059	0.00291	CcSEcCtD
Sulindac—ALB—brain—Alzheimer's disease	0.000587	0.00799	CbGeAlD
Sulindac—Convulsion—Galantamine—Alzheimer's disease	0.000586	0.00288	CcSEcCtD
Sulindac—Renal failure—Rivastigmine—Alzheimer's disease	0.000585	0.00288	CcSEcCtD
Sulindac—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000584	0.00287	CcSEcCtD
Sulindac—Hypertension—Galantamine—Alzheimer's disease	0.000583	0.00287	CcSEcCtD
Sulindac—Haematuria—Memantine—Alzheimer's disease	0.00058	0.00286	CcSEcCtD
Sulindac—Visual impairment—Donepezil—Alzheimer's disease	0.00058	0.00285	CcSEcCtD
Sulindac—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000579	0.00285	CcSEcCtD
Sulindac—Myalgia—Galantamine—Alzheimer's disease	0.000575	0.00283	CcSEcCtD
Sulindac—Chest pain—Galantamine—Alzheimer's disease	0.000575	0.00283	CcSEcCtD
Sulindac—Arthralgia—Galantamine—Alzheimer's disease	0.000575	0.00283	CcSEcCtD
Sulindac—Epistaxis—Memantine—Alzheimer's disease	0.000574	0.00283	CcSEcCtD
Sulindac—Sweating—Rivastigmine—Alzheimer's disease	0.000571	0.00281	CcSEcCtD
Sulindac—Discomfort—Galantamine—Alzheimer's disease	0.000568	0.0028	CcSEcCtD
Sulindac—Agranulocytosis—Memantine—Alzheimer's disease	0.000568	0.0028	CcSEcCtD
Sulindac—Haematuria—Rivastigmine—Alzheimer's disease	0.000568	0.00279	CcSEcCtD
Sulindac—Epistaxis—Rivastigmine—Alzheimer's disease	0.000561	0.00276	CcSEcCtD
Sulindac—Tinnitus—Donepezil—Alzheimer's disease	0.000561	0.00276	CcSEcCtD
Sulindac—Hepatitis—Memantine—Alzheimer's disease	0.000546	0.00269	CcSEcCtD
Sulindac—Shock—Galantamine—Alzheimer's disease	0.000543	0.00267	CcSEcCtD
Sulindac—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00054	0.00266	CcSEcCtD
Sulindac—Chills—Donepezil—Alzheimer's disease	0.00054	0.00266	CcSEcCtD
Sulindac—Tachycardia—Galantamine—Alzheimer's disease	0.000538	0.00265	CcSEcCtD
Sulindac—Arrhythmia—Donepezil—Alzheimer's disease	0.000537	0.00265	CcSEcCtD
Sulindac—Hepatitis—Rivastigmine—Alzheimer's disease	0.000534	0.00263	CcSEcCtD
Sulindac—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000533	0.00263	CcSEcCtD
Sulindac—Alopecia—Donepezil—Alzheimer's disease	0.000532	0.00262	CcSEcCtD
Sulindac—Visual impairment—Memantine—Alzheimer's disease	0.000526	0.00259	CcSEcCtD
Sulindac—Anorexia—Galantamine—Alzheimer's disease	0.000526	0.00259	CcSEcCtD
Sulindac—Erythema multiforme—Memantine—Alzheimer's disease	0.000517	0.00254	CcSEcCtD
Sulindac—Flatulence—Donepezil—Alzheimer's disease	0.000516	0.00254	CcSEcCtD
Sulindac—Hypotension—Galantamine—Alzheimer's disease	0.000515	0.00254	CcSEcCtD
Sulindac—Visual impairment—Rivastigmine—Alzheimer's disease	0.000515	0.00254	CcSEcCtD
Sulindac—Tension—Donepezil—Alzheimer's disease	0.000514	0.00253	CcSEcCtD
Sulindac—Dysgeusia—Donepezil—Alzheimer's disease	0.000513	0.00253	CcSEcCtD
Sulindac—Tinnitus—Memantine—Alzheimer's disease	0.000509	0.00251	CcSEcCtD
Sulindac—Nervousness—Donepezil—Alzheimer's disease	0.000509	0.0025	CcSEcCtD
Sulindac—Flushing—Memantine—Alzheimer's disease	0.000507	0.0025	CcSEcCtD
Sulindac—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000505	0.00249	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000502	0.00247	CcSEcCtD
Sulindac—Insomnia—Galantamine—Alzheimer's disease	0.000499	0.00246	CcSEcCtD
Sulindac—Tinnitus—Rivastigmine—Alzheimer's disease	0.000498	0.00245	CcSEcCtD
Sulindac—CYP1A1—nervous system—Alzheimer's disease	0.000498	0.00678	CbGeAlD
Sulindac—Flushing—Rivastigmine—Alzheimer's disease	0.000496	0.00244	CcSEcCtD
Sulindac—Paraesthesia—Galantamine—Alzheimer's disease	0.000495	0.00244	CcSEcCtD
Sulindac—Vision blurred—Donepezil—Alzheimer's disease	0.000494	0.00243	CcSEcCtD
Sulindac—Somnolence—Galantamine—Alzheimer's disease	0.00049	0.00241	CcSEcCtD
Sulindac—Chills—Memantine—Alzheimer's disease	0.00049	0.00241	CcSEcCtD
Sulindac—Arrhythmia—Memantine—Alzheimer's disease	0.000488	0.0024	CcSEcCtD
Sulindac—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000486	0.00239	CcSEcCtD
Sulindac—Dyspepsia—Galantamine—Alzheimer's disease	0.000485	0.00239	CcSEcCtD
Sulindac—Anaemia—Donepezil—Alzheimer's disease	0.000484	0.00238	CcSEcCtD
Sulindac—Alopecia—Memantine—Alzheimer's disease	0.000483	0.00238	CcSEcCtD
Sulindac—CYP1A1—central nervous system—Alzheimer's disease	0.00048	0.00653	CbGeAlD
Sulindac—Chills—Rivastigmine—Alzheimer's disease	0.00048	0.00236	CcSEcCtD
Sulindac—Decreased appetite—Galantamine—Alzheimer's disease	0.000479	0.00236	CcSEcCtD
Sulindac—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000477	0.00235	CcSEcCtD
Sulindac—Fatigue—Galantamine—Alzheimer's disease	0.000476	0.00234	CcSEcCtD
Sulindac—Malaise—Donepezil—Alzheimer's disease	0.000472	0.00233	CcSEcCtD
Sulindac—Alopecia—Rivastigmine—Alzheimer's disease	0.000472	0.00233	CcSEcCtD
Sulindac—Constipation—Galantamine—Alzheimer's disease	0.000472	0.00232	CcSEcCtD
Sulindac—Vertigo—Donepezil—Alzheimer's disease	0.000471	0.00232	CcSEcCtD
Sulindac—Syncope—Donepezil—Alzheimer's disease	0.00047	0.00231	CcSEcCtD
Sulindac—Flatulence—Memantine—Alzheimer's disease	0.000469	0.00231	CcSEcCtD
Sulindac—Tension—Memantine—Alzheimer's disease	0.000467	0.0023	CcSEcCtD
Sulindac—Dysgeusia—Memantine—Alzheimer's disease	0.000466	0.00229	CcSEcCtD
Sulindac—Nervousness—Memantine—Alzheimer's disease	0.000462	0.00227	CcSEcCtD
Sulindac—Loss of consciousness—Donepezil—Alzheimer's disease	0.00046	0.00227	CcSEcCtD
Sulindac—Flatulence—Rivastigmine—Alzheimer's disease	0.000458	0.00226	CcSEcCtD
Sulindac—Tension—Rivastigmine—Alzheimer's disease	0.000457	0.00225	CcSEcCtD
Sulindac—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000456	0.00224	CcSEcCtD
Sulindac—Feeling abnormal—Galantamine—Alzheimer's disease	0.000455	0.00224	CcSEcCtD
Sulindac—Convulsion—Donepezil—Alzheimer's disease	0.000454	0.00223	CcSEcCtD
Sulindac—Hypertension—Donepezil—Alzheimer's disease	0.000452	0.00223	CcSEcCtD
Sulindac—Nervousness—Rivastigmine—Alzheimer's disease	0.000452	0.00222	CcSEcCtD
Sulindac—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000451	0.00222	CcSEcCtD
Sulindac—Vision blurred—Memantine—Alzheimer's disease	0.000448	0.00221	CcSEcCtD
Sulindac—Arthralgia—Donepezil—Alzheimer's disease	0.000446	0.0022	CcSEcCtD
Sulindac—Myalgia—Donepezil—Alzheimer's disease	0.000446	0.0022	CcSEcCtD
Sulindac—Chest pain—Donepezil—Alzheimer's disease	0.000446	0.0022	CcSEcCtD
Sulindac—Ill-defined disorder—Memantine—Alzheimer's disease	0.000441	0.00217	CcSEcCtD
Sulindac—Discomfort—Donepezil—Alzheimer's disease	0.000441	0.00217	CcSEcCtD
Sulindac—Anaemia—Memantine—Alzheimer's disease	0.00044	0.00216	CcSEcCtD
Sulindac—Vision blurred—Rivastigmine—Alzheimer's disease	0.000438	0.00216	CcSEcCtD
Sulindac—PTGS1—nervous system—Alzheimer's disease	0.000438	0.00596	CbGeAlD
Sulindac—Body temperature increased—Galantamine—Alzheimer's disease	0.000436	0.00215	CcSEcCtD
Sulindac—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000432	0.00213	CcSEcCtD
Sulindac—Anaemia—Rivastigmine—Alzheimer's disease	0.00043	0.00212	CcSEcCtD
Sulindac—Malaise—Memantine—Alzheimer's disease	0.000429	0.00211	CcSEcCtD
Sulindac—Oedema—Donepezil—Alzheimer's disease	0.000427	0.0021	CcSEcCtD
Sulindac—Vertigo—Memantine—Alzheimer's disease	0.000427	0.0021	CcSEcCtD
Sulindac—Syncope—Memantine—Alzheimer's disease	0.000426	0.0021	CcSEcCtD
Sulindac—Leukopenia—Memantine—Alzheimer's disease	0.000426	0.0021	CcSEcCtD
Sulindac—PTGS1—central nervous system—Alzheimer's disease	0.000421	0.00574	CbGeAlD
Sulindac—Shock—Donepezil—Alzheimer's disease	0.000421	0.00207	CcSEcCtD
Sulindac—Palpitations—Memantine—Alzheimer's disease	0.00042	0.00207	CcSEcCtD
Sulindac—Malaise—Rivastigmine—Alzheimer's disease	0.00042	0.00207	CcSEcCtD
Sulindac—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000419	0.00206	CcSEcCtD
Sulindac—PTGS2—nervous system—Alzheimer's disease	0.000418	0.0057	CbGeAlD
Sulindac—Vertigo—Rivastigmine—Alzheimer's disease	0.000418	0.00206	CcSEcCtD
Sulindac—Loss of consciousness—Memantine—Alzheimer's disease	0.000418	0.00206	CcSEcCtD
Sulindac—Syncope—Rivastigmine—Alzheimer's disease	0.000417	0.00205	CcSEcCtD
Sulindac—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000413	0.00203	CcSEcCtD
Sulindac—Convulsion—Memantine—Alzheimer's disease	0.000412	0.00203	CcSEcCtD
Sulindac—Palpitations—Rivastigmine—Alzheimer's disease	0.000411	0.00202	CcSEcCtD
Sulindac—Hypertension—Memantine—Alzheimer's disease	0.000411	0.00202	CcSEcCtD
Sulindac—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000409	0.00201	CcSEcCtD
Sulindac—Anorexia—Donepezil—Alzheimer's disease	0.000407	0.00201	CcSEcCtD
Sulindac—Hypersensitivity—Galantamine—Alzheimer's disease	0.000406	0.002	CcSEcCtD
Sulindac—Chest pain—Memantine—Alzheimer's disease	0.000405	0.00199	CcSEcCtD
Sulindac—Myalgia—Memantine—Alzheimer's disease	0.000405	0.00199	CcSEcCtD
Sulindac—Arthralgia—Memantine—Alzheimer's disease	0.000405	0.00199	CcSEcCtD
Sulindac—Convulsion—Rivastigmine—Alzheimer's disease	0.000403	0.00198	CcSEcCtD
Sulindac—PTGS2—central nervous system—Alzheimer's disease	0.000403	0.00548	CbGeAlD
Sulindac—Hypertension—Rivastigmine—Alzheimer's disease	0.000402	0.00198	CcSEcCtD
Sulindac—Discomfort—Memantine—Alzheimer's disease	0.0004	0.00197	CcSEcCtD
Sulindac—Hypotension—Donepezil—Alzheimer's disease	0.000399	0.00197	CcSEcCtD
Sulindac—Arthralgia—Rivastigmine—Alzheimer's disease	0.000396	0.00195	CcSEcCtD
Sulindac—Myalgia—Rivastigmine—Alzheimer's disease	0.000396	0.00195	CcSEcCtD
Sulindac—Chest pain—Rivastigmine—Alzheimer's disease	0.000396	0.00195	CcSEcCtD
Sulindac—Asthenia—Galantamine—Alzheimer's disease	0.000396	0.00195	CcSEcCtD
Sulindac—PTGS2—cerebellum—Alzheimer's disease	0.000394	0.00536	CbGeAlD
Sulindac—Discomfort—Rivastigmine—Alzheimer's disease	0.000391	0.00193	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000389	0.00192	CcSEcCtD
Sulindac—Oedema—Memantine—Alzheimer's disease	0.000388	0.00191	CcSEcCtD
Sulindac—Insomnia—Donepezil—Alzheimer's disease	0.000387	0.0019	CcSEcCtD
Sulindac—Paraesthesia—Donepezil—Alzheimer's disease	0.000384	0.00189	CcSEcCtD
Sulindac—Shock—Memantine—Alzheimer's disease	0.000382	0.00188	CcSEcCtD
Sulindac—Dyspnoea—Donepezil—Alzheimer's disease	0.000381	0.00188	CcSEcCtD
Sulindac—CYP1A1—brain—Alzheimer's disease	0.000381	0.00519	CbGeAlD
Sulindac—Somnolence—Donepezil—Alzheimer's disease	0.00038	0.00187	CcSEcCtD
Sulindac—Thrombocytopenia—Memantine—Alzheimer's disease	0.00038	0.00187	CcSEcCtD
Sulindac—Oedema—Rivastigmine—Alzheimer's disease	0.00038	0.00187	CcSEcCtD
Sulindac—Tachycardia—Memantine—Alzheimer's disease	0.000379	0.00187	CcSEcCtD
Sulindac—Diarrhoea—Galantamine—Alzheimer's disease	0.000377	0.00186	CcSEcCtD
Sulindac—Dyspepsia—Donepezil—Alzheimer's disease	0.000376	0.00185	CcSEcCtD
Sulindac—Hyperhidrosis—Memantine—Alzheimer's disease	0.000375	0.00185	CcSEcCtD
Sulindac—Shock—Rivastigmine—Alzheimer's disease	0.000374	0.00184	CcSEcCtD
Sulindac—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000372	0.00183	CcSEcCtD
Sulindac—Decreased appetite—Donepezil—Alzheimer's disease	0.000372	0.00183	CcSEcCtD
Sulindac—Tachycardia—Rivastigmine—Alzheimer's disease	0.000371	0.00182	CcSEcCtD
Sulindac—Anorexia—Memantine—Alzheimer's disease	0.00037	0.00182	CcSEcCtD
Sulindac—Fatigue—Donepezil—Alzheimer's disease	0.000369	0.00181	CcSEcCtD
Sulindac—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000367	0.00181	CcSEcCtD
Sulindac—Constipation—Donepezil—Alzheimer's disease	0.000366	0.0018	CcSEcCtD
Sulindac—Dizziness—Galantamine—Alzheimer's disease	0.000365	0.0018	CcSEcCtD
Sulindac—Hypotension—Memantine—Alzheimer's disease	0.000363	0.00179	CcSEcCtD
Sulindac—Anorexia—Rivastigmine—Alzheimer's disease	0.000362	0.00178	CcSEcCtD
Sulindac—Hypotension—Rivastigmine—Alzheimer's disease	0.000355	0.00175	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000354	0.00174	CcSEcCtD
Sulindac—Feeling abnormal—Donepezil—Alzheimer's disease	0.000352	0.00173	CcSEcCtD
Sulindac—Insomnia—Memantine—Alzheimer's disease	0.000351	0.00173	CcSEcCtD
Sulindac—Vomiting—Galantamine—Alzheimer's disease	0.000351	0.00173	CcSEcCtD
Sulindac—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00035	0.00172	CcSEcCtD
Sulindac—Paraesthesia—Memantine—Alzheimer's disease	0.000348	0.00172	CcSEcCtD
Sulindac—Rash—Galantamine—Alzheimer's disease	0.000348	0.00171	CcSEcCtD
Sulindac—Dermatitis—Galantamine—Alzheimer's disease	0.000347	0.00171	CcSEcCtD
Sulindac—Dyspnoea—Memantine—Alzheimer's disease	0.000346	0.0017	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000346	0.0017	CcSEcCtD
Sulindac—Headache—Galantamine—Alzheimer's disease	0.000346	0.0017	CcSEcCtD
Sulindac—Somnolence—Memantine—Alzheimer's disease	0.000345	0.0017	CcSEcCtD
Sulindac—Insomnia—Rivastigmine—Alzheimer's disease	0.000343	0.00169	CcSEcCtD
Sulindac—Dyspepsia—Memantine—Alzheimer's disease	0.000342	0.00168	CcSEcCtD
Sulindac—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000341	0.00168	CcSEcCtD
Sulindac—Urticaria—Donepezil—Alzheimer's disease	0.00034	0.00167	CcSEcCtD
Sulindac—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000338	0.00167	CcSEcCtD
Sulindac—Body temperature increased—Donepezil—Alzheimer's disease	0.000338	0.00166	CcSEcCtD
Sulindac—Somnolence—Rivastigmine—Alzheimer's disease	0.000338	0.00166	CcSEcCtD
Sulindac—Decreased appetite—Memantine—Alzheimer's disease	0.000337	0.00166	CcSEcCtD
Sulindac—Fatigue—Memantine—Alzheimer's disease	0.000335	0.00165	CcSEcCtD
Sulindac—PTGS1—brain—Alzheimer's disease	0.000335	0.00456	CbGeAlD
Sulindac—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000334	0.00165	CcSEcCtD
Sulindac—Constipation—Memantine—Alzheimer's disease	0.000332	0.00163	CcSEcCtD
Sulindac—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00033	0.00163	CcSEcCtD
Sulindac—Nausea—Galantamine—Alzheimer's disease	0.000328	0.00161	CcSEcCtD
Sulindac—Fatigue—Rivastigmine—Alzheimer's disease	0.000327	0.00161	CcSEcCtD
Sulindac—Constipation—Rivastigmine—Alzheimer's disease	0.000325	0.0016	CcSEcCtD
Sulindac—Feeling abnormal—Memantine—Alzheimer's disease	0.00032	0.00157	CcSEcCtD
Sulindac—PTGS2—brain—Alzheimer's disease	0.00032	0.00435	CbGeAlD
Sulindac—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000317	0.00156	CcSEcCtD
Sulindac—Hypersensitivity—Donepezil—Alzheimer's disease	0.000315	0.00155	CcSEcCtD
Sulindac—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000313	0.00154	CcSEcCtD
Sulindac—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00031	0.00153	CcSEcCtD
Sulindac—Urticaria—Memantine—Alzheimer's disease	0.000308	0.00152	CcSEcCtD
Sulindac—Body temperature increased—Memantine—Alzheimer's disease	0.000307	0.00151	CcSEcCtD
Sulindac—Asthenia—Donepezil—Alzheimer's disease	0.000307	0.00151	CcSEcCtD
Sulindac—Pruritus—Donepezil—Alzheimer's disease	0.000302	0.00149	CcSEcCtD
Sulindac—Urticaria—Rivastigmine—Alzheimer's disease	0.000302	0.00149	CcSEcCtD
Sulindac—Body temperature increased—Rivastigmine—Alzheimer's disease	0.0003	0.00148	CcSEcCtD
Sulindac—Diarrhoea—Donepezil—Alzheimer's disease	0.000292	0.00144	CcSEcCtD
Sulindac—Hypersensitivity—Memantine—Alzheimer's disease	0.000286	0.00141	CcSEcCtD
Sulindac—Dizziness—Donepezil—Alzheimer's disease	0.000283	0.00139	CcSEcCtD
Sulindac—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00028	0.00138	CcSEcCtD
Sulindac—Asthenia—Memantine—Alzheimer's disease	0.000278	0.00137	CcSEcCtD
Sulindac—Pruritus—Memantine—Alzheimer's disease	0.000275	0.00135	CcSEcCtD
Sulindac—Asthenia—Rivastigmine—Alzheimer's disease	0.000272	0.00134	CcSEcCtD
Sulindac—Vomiting—Donepezil—Alzheimer's disease	0.000272	0.00134	CcSEcCtD
Sulindac—Rash—Donepezil—Alzheimer's disease	0.00027	0.00133	CcSEcCtD
Sulindac—Dermatitis—Donepezil—Alzheimer's disease	0.000269	0.00133	CcSEcCtD
Sulindac—Pruritus—Rivastigmine—Alzheimer's disease	0.000269	0.00132	CcSEcCtD
Sulindac—Headache—Donepezil—Alzheimer's disease	0.000268	0.00132	CcSEcCtD
Sulindac—Diarrhoea—Memantine—Alzheimer's disease	0.000266	0.00131	CcSEcCtD
Sulindac—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00026	0.00128	CcSEcCtD
Sulindac—Dizziness—Memantine—Alzheimer's disease	0.000257	0.00126	CcSEcCtD
Sulindac—Nausea—Donepezil—Alzheimer's disease	0.000254	0.00125	CcSEcCtD
Sulindac—Dizziness—Rivastigmine—Alzheimer's disease	0.000251	0.00124	CcSEcCtD
Sulindac—Vomiting—Memantine—Alzheimer's disease	0.000247	0.00121	CcSEcCtD
Sulindac—Rash—Memantine—Alzheimer's disease	0.000245	0.0012	CcSEcCtD
Sulindac—Dermatitis—Memantine—Alzheimer's disease	0.000244	0.0012	CcSEcCtD
Sulindac—Headache—Memantine—Alzheimer's disease	0.000243	0.0012	CcSEcCtD
Sulindac—Vomiting—Rivastigmine—Alzheimer's disease	0.000241	0.00119	CcSEcCtD
Sulindac—Rash—Rivastigmine—Alzheimer's disease	0.000239	0.00118	CcSEcCtD
Sulindac—Dermatitis—Rivastigmine—Alzheimer's disease	0.000239	0.00118	CcSEcCtD
Sulindac—Headache—Rivastigmine—Alzheimer's disease	0.000238	0.00117	CcSEcCtD
Sulindac—Nausea—Memantine—Alzheimer's disease	0.000231	0.00114	CcSEcCtD
Sulindac—Nausea—Rivastigmine—Alzheimer's disease	0.000226	0.00111	CcSEcCtD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.32e-05	6.86e-05	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—IL6—Alzheimer's disease	1.31e-05	6.82e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CYP2D6—Alzheimer's disease	1.31e-05	6.81e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CCR5—Alzheimer's disease	1.31e-05	6.8e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PLCB1—Alzheimer's disease	1.31e-05	6.8e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—A2M—Alzheimer's disease	1.3e-05	6.76e-05	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.3e-05	6.76e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CHAT—Alzheimer's disease	1.3e-05	6.73e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—TPI1—Alzheimer's disease	1.3e-05	6.73e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—MAPK8—Alzheimer's disease	1.3e-05	6.73e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CALM1—Alzheimer's disease	1.3e-05	6.73e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.29e-05	6.68e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.28e-05	6.66e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—MTHFR—Alzheimer's disease	1.28e-05	6.65e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—ENO1—Alzheimer's disease	1.27e-05	6.58e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PPP3CA—Alzheimer's disease	1.26e-05	6.55e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.25e-05	6.51e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TGFB1—Alzheimer's disease	1.24e-05	6.46e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MAOB—Alzheimer's disease	1.24e-05	6.45e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—BCHE—Alzheimer's disease	1.24e-05	6.45e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	1.24e-05	6.44e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—ESR1—Alzheimer's disease	1.23e-05	6.36e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NGFR—Alzheimer's disease	1.22e-05	6.34e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TGFB1—Alzheimer's disease	1.22e-05	6.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CREB1—Alzheimer's disease	1.21e-05	6.3e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—GAB2—Alzheimer's disease	1.21e-05	6.28e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PLAU—Alzheimer's disease	1.2e-05	6.24e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—GSK3A—Alzheimer's disease	1.2e-05	6.22e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—GAPDH—Alzheimer's disease	1.2e-05	6.21e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CALM1—Alzheimer's disease	1.2e-05	6.21e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ADAM10—Alzheimer's disease	1.19e-05	6.19e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—APOE—Alzheimer's disease	1.19e-05	6.19e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—CALM1—Alzheimer's disease	1.19e-05	6.17e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—CCL2—Alzheimer's disease	1.19e-05	6.17e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—Alzheimer's disease	1.19e-05	6.16e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NOTCH1—Alzheimer's disease	1.19e-05	6.15e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.18e-05	6.14e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—TPI1—Alzheimer's disease	1.18e-05	6.14e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CHAT—Alzheimer's disease	1.18e-05	6.14e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CAV1—Alzheimer's disease	1.18e-05	6.13e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APP—Alzheimer's disease	1.18e-05	6.12e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—CAV1—Alzheimer's disease	1.17e-05	6.09e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PLCB1—Alzheimer's disease	1.17e-05	6.09e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.17e-05	6.09e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.16e-05	6.03e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—TNF—Alzheimer's disease	1.16e-05	6.03e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—A2M—Alzheimer's disease	1.16e-05	6e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.15e-05	5.97e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.15e-05	5.95e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	1.14e-05	5.91e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ABCA1—Alzheimer's disease	1.14e-05	5.9e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—MAOB—Alzheimer's disease	1.13e-05	5.88e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ACHE—Alzheimer's disease	1.13e-05	5.88e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—S100B—Alzheimer's disease	1.13e-05	5.86e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—INPP5D—Alzheimer's disease	1.12e-05	5.81e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—PPARG—Alzheimer's disease	1.12e-05	5.81e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—GSK3B—Alzheimer's disease	1.12e-05	5.81e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—F2—Alzheimer's disease	1.12e-05	5.8e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS2—Alzheimer's disease	1.11e-05	5.77e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CREB1—Alzheimer's disease	1.11e-05	5.76e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS2—Alzheimer's disease	1.1e-05	5.73e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOTCH1—Alzheimer's disease	1.1e-05	5.71e-05	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.1e-05	5.71e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—GAPDH—Alzheimer's disease	1.09e-05	5.66e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL6—Alzheimer's disease	1.09e-05	5.64e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.08e-05	5.6e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF2—Alzheimer's disease	1.07e-05	5.58e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.07e-05	5.55e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PTGS1—Alzheimer's disease	1.06e-05	5.51e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ENO1—Alzheimer's disease	1.06e-05	5.51e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—A2M—Alzheimer's disease	1.05e-05	5.47e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	1.04e-05	5.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF1R—Alzheimer's disease	1.04e-05	5.39e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—GSK3B—Alzheimer's disease	1.03e-05	5.36e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.03e-05	5.35e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CREB1—Alzheimer's disease	1.02e-05	5.32e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—INS—Alzheimer's disease	1.02e-05	5.29e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—ADAM10—Alzheimer's disease	1.01e-05	5.26e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ACHE—Alzheimer's disease	1.01e-05	5.22e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—Alzheimer's disease	1e-05	5.21e-05	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—AKT1—Alzheimer's disease	1e-05	5.2e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LPL—Alzheimer's disease	9.96e-06	5.17e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—INPP5D—Alzheimer's disease	9.94e-06	5.16e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	9.89e-06	5.13e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MEF2C—Alzheimer's disease	9.87e-06	5.12e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—BCHE—Alzheimer's disease	9.87e-06	5.12e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARGC1A—Alzheimer's disease	9.8e-06	5.09e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IGF1—Alzheimer's disease	9.79e-06	5.08e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—HMOX1—Alzheimer's disease	9.76e-06	5.06e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PRKCG—Alzheimer's disease	9.69e-06	5.03e-05	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—Alzheimer's disease	9.48e-06	4.92e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NGF—Alzheimer's disease	9.43e-06	4.9e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS1—Alzheimer's disease	9.42e-06	4.89e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ENO1—Alzheimer's disease	9.42e-06	4.89e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.4e-06	4.88e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—IL6—Alzheimer's disease	9.37e-06	4.86e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—BCL2—Alzheimer's disease	9.32e-06	4.83e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PLCB1—Alzheimer's disease	9.31e-06	4.83e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP2D6—Alzheimer's disease	9.24e-06	4.8e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCR5—Alzheimer's disease	9.18e-06	4.76e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ACHE—Alzheimer's disease	9.17e-06	4.76e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—INPP5D—Alzheimer's disease	9.06e-06	4.7e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ABCA1—Alzheimer's disease	9.03e-06	4.69e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	9e-06	4.67e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HTR2A—Alzheimer's disease	8.98e-06	4.66e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOS3—Alzheimer's disease	8.93e-06	4.64e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—LPL—Alzheimer's disease	8.92e-06	4.63e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—NOS3—Alzheimer's disease	8.88e-06	4.61e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—BCHE—Alzheimer's disease	8.76e-06	4.55e-05	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—AKT1—Alzheimer's disease	8.66e-06	4.5e-05	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—AKT1—Alzheimer's disease	8.65e-06	4.49e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ENO1—Alzheimer's disease	8.59e-06	4.46e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS1—Alzheimer's disease	8.59e-06	4.46e-05	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—AKT1—Alzheimer's disease	8.48e-06	4.4e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—LPL—Alzheimer's disease	8.46e-06	4.39e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP2D6—Alzheimer's disease	8.42e-06	4.37e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CALM1—Alzheimer's disease	8.38e-06	4.35e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—LEP—Alzheimer's disease	8.35e-06	4.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APOE—Alzheimer's disease	8.35e-06	4.33e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IL6—Alzheimer's disease	8.28e-06	4.3e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CAV1—Alzheimer's disease	8.27e-06	4.29e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—TPI1—Alzheimer's disease	8.27e-06	4.29e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CHAT—Alzheimer's disease	8.27e-06	4.29e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PLCB1—Alzheimer's disease	8.27e-06	4.29e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL1B—Alzheimer's disease	8.23e-06	4.27e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PRKCG—Alzheimer's disease	8.23e-06	4.27e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—PTGS2—Alzheimer's disease	8.17e-06	4.24e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.11e-06	4.21e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTHFR—Alzheimer's disease	8.04e-06	4.17e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ABCA1—Alzheimer's disease	8.01e-06	4.16e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—BCHE—Alzheimer's disease	7.99e-06	4.15e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ESR1—Alzheimer's disease	7.97e-06	4.14e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MAOB—Alzheimer's disease	7.93e-06	4.12e-05	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	7.92e-06	4.11e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—F2—Alzheimer's disease	7.87e-06	4.09e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CCR5—Alzheimer's disease	7.79e-06	4.05e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	7.78e-06	4.04e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—HMOX1—Alzheimer's disease	7.75e-06	4.02e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOTCH1—Alzheimer's disease	7.71e-06	4e-05	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—AKT1—Alzheimer's disease	7.64e-06	3.96e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	7.63e-06	3.96e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTHFR—Alzheimer's disease	7.62e-06	3.95e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—MAPK8—Alzheimer's disease	7.55e-06	3.92e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	7.55e-06	3.92e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PLCB1—Alzheimer's disease	7.54e-06	3.91e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CALM1—Alzheimer's disease	7.51e-06	3.9e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—APOE—Alzheimer's disease	7.48e-06	3.88e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	7.48e-06	3.88e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CAV1—Alzheimer's disease	7.41e-06	3.85e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.39e-06	3.84e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—A2M—Alzheimer's disease	7.37e-06	3.83e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—ABCA1—Alzheimer's disease	7.3e-06	3.79e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GSK3B—Alzheimer's disease	7.23e-06	3.75e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CREB1—Alzheimer's disease	7.17e-06	3.72e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—INS—Alzheimer's disease	7.13e-06	3.7e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CALM1—Alzheimer's disease	7.12e-06	3.69e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APOE—Alzheimer's disease	7.09e-06	3.68e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—LPL—Alzheimer's disease	7.08e-06	3.68e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CAV1—Alzheimer's disease	7.03e-06	3.65e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCL2—Alzheimer's disease	7.02e-06	3.64e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	6.91e-06	3.58e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IGF1—Alzheimer's disease	6.9e-06	3.58e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	6.87e-06	3.57e-05	CbGpPWpGaD
Sulindac—PPARD—Metabolism—AKT1—Alzheimer's disease	6.74e-06	3.5e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS2—Alzheimer's disease	6.61e-06	3.43e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.57e-06	3.41e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOTCH1—Alzheimer's disease	6.54e-06	3.4e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PPARG—Alzheimer's disease	6.52e-06	3.38e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ACHE—Alzheimer's disease	6.41e-06	3.33e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VEGFA—Alzheimer's disease	6.4e-06	3.32e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—INS—Alzheimer's disease	6.39e-06	3.32e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTHFR—Alzheimer's disease	6.38e-06	3.31e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	6.34e-06	3.29e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARGC1A—Alzheimer's disease	6.3e-06	3.27e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—LPL—Alzheimer's disease	6.29e-06	3.26e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—HMOX1—Alzheimer's disease	6.27e-06	3.25e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOS3—Alzheimer's disease	6.26e-06	3.25e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—GSK3B—Alzheimer's disease	6.14e-06	3.19e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CREB1—Alzheimer's disease	6.09e-06	3.16e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—INS—Alzheimer's disease	6.06e-06	3.14e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	6.01e-06	3.12e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ENO1—Alzheimer's disease	6.01e-06	3.12e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CALM1—Alzheimer's disease	5.96e-06	3.09e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—APOE—Alzheimer's disease	5.94e-06	3.08e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—TGFB1—Alzheimer's disease	5.91e-06	3.07e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	5.89e-06	3.06e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CAV1—Alzheimer's disease	5.88e-06	3.05e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TGFB1—Alzheimer's disease	5.87e-06	3.05e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—LPL—Alzheimer's disease	5.73e-06	2.97e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	5.66e-06	2.94e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—NOS3—Alzheimer's disease	5.6e-06	2.91e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—BCHE—Alzheimer's disease	5.59e-06	2.9e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOS3—Alzheimer's disease	5.31e-06	2.76e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CASP3—Alzheimer's disease	5.31e-06	2.76e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CALM1—Alzheimer's disease	5.29e-06	2.75e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL6—Alzheimer's disease	5.28e-06	2.74e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	5.27e-06	2.74e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—APOE—Alzheimer's disease	5.27e-06	2.74e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CAV1—Alzheimer's disease	5.22e-06	2.71e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PPARG—Alzheimer's disease	5.17e-06	2.68e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.17e-06	2.68e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTHFR—Alzheimer's disease	5.16e-06	2.68e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PTGS2—Alzheimer's disease	5.13e-06	2.66e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	5.11e-06	2.65e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—INS—Alzheimer's disease	5.07e-06	2.63e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MAPK8—Alzheimer's disease	4.88e-06	2.53e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AKT1—Alzheimer's disease	4.87e-06	2.53e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—Alzheimer's disease	4.83e-06	2.51e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CALM1—Alzheimer's disease	4.82e-06	2.5e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL6—Alzheimer's disease	4.82e-06	2.5e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—APOE—Alzheimer's disease	4.8e-06	2.49e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—CAV1—Alzheimer's disease	4.76e-06	2.47e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PPARG—Alzheimer's disease	4.59e-06	2.38e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VEGFA—Alzheimer's disease	4.51e-06	2.34e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—INS—Alzheimer's disease	4.5e-06	2.34e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—IL6—Alzheimer's disease	4.45e-06	2.31e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—NOS3—Alzheimer's disease	4.45e-06	2.31e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—AKT1—Alzheimer's disease	4.45e-06	2.31e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—AKT1—Alzheimer's disease	4.42e-06	2.3e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	4.4e-06	2.29e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	4.38e-06	2.28e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PPARG—Alzheimer's disease	4.18e-06	2.17e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TGFB1—Alzheimer's disease	4.14e-06	2.15e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—AKT1—Alzheimer's disease	4.11e-06	2.13e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—INS—Alzheimer's disease	4.1e-06	2.13e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—AKT1—Alzheimer's disease	4.08e-06	2.12e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—LPL—Alzheimer's disease	4.01e-06	2.08e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—NOS3—Alzheimer's disease	3.95e-06	2.05e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	3.61e-06	1.87e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	3.61e-06	1.87e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—NOS3—Alzheimer's disease	3.6e-06	1.87e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—TGFB1—Alzheimer's disease	3.51e-06	1.82e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—Alzheimer's disease	3.41e-06	1.77e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CALM1—Alzheimer's disease	3.37e-06	1.75e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—APOE—Alzheimer's disease	3.36e-06	1.74e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CAV1—Alzheimer's disease	3.33e-06	1.73e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PTGS2—Alzheimer's disease	3.29e-06	1.71e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL6—Alzheimer's disease	3.12e-06	1.62e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.93e-06	1.52e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AKT1—Alzheimer's disease	2.88e-06	1.49e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—INS—Alzheimer's disease	2.87e-06	1.49e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IL6—Alzheimer's disease	2.65e-06	1.37e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—AKT1—Alzheimer's disease	2.58e-06	1.34e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.52e-06	1.31e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—AKT1—Alzheimer's disease	2.44e-06	1.27e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.3e-06	1.2e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—AKT1—Alzheimer's disease	2.05e-06	1.06e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—AKT1—Alzheimer's disease	1.82e-06	9.42e-06	CbGpPWpGaD
Sulindac—ALB—Metabolism—AKT1—Alzheimer's disease	1.65e-06	8.59e-06	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.16e-06	6.01e-06	CbGpPWpGaD
